Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Feb 7, 2025; 31(5): 102249
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.102249
Figure 1
Figure 1 Flow chart depicting the screening of gastric cancer patients who received sintilimab combined with chemotherapy. PD-1: Programmed cell death protein 1; PD-L1: Programmed cell death ligand 1; TyG: Triglyceride glucose.